XWELL
XWEL

$2.08

7.96%

Market Cap: 8.7M

About: XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Employees: 337

Consumer Discretionary Personal Services

0

Funds holding %

of 6,702 funds

–

Analysts bullish %

–

News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

6% more funds holding

Funds holding: 17 [Q4 2023] → 18 (+1) [Q1 2024]

1.44% less ownership

Funds ownership: 8.65% [Q4 2023] → 7.21% (-1.44%) [Q1 2024]

19% less capital invested

Capital invested by funds: $627K [Q4 2023] → $507K (-$120K) [Q1 2024]

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for XWEL.

See Analyst Rankings

Financial journalist opinion

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Today, CPC Pain & Wellness SPV, LLC (“CPC”), a significant XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”) shareholder that beneficially owns 394,200 or 9.42% of XWELL's outstanding shares, issued the below letter to its fellow shareholders. The letter informs shareholders of CPC's recent lawsuit filing against the incumbent members of XWELL's Board of Directors for breach of their fiduciary duties and for the Board's wrongful and inequitable efforts to prevent CPC from nominating a competing slate of directors and consequently denying shareholders the opportunity to choose who they elect to XWELL's Board at the upcoming annual shareholder meeting. In its letter, CPC details how current Board members have personally benefited from XWELL while overseeing an astounding decline in XWELL shareholder value and substantial net losses. CPC also shares in the below letter its vision for restoring and maximizing shareholder value.

CPC Issues Letter to Fellow XWELL, Inc. Shareholders Revealing Intention Behind Recent Schedule 13D Filing & Lawsuit Against Entrenched Board of Directors

XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid

NEW YORK--(BUSINESS WIRE)--XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in wellness solutions for people on the go, today announced that the notice materials submitted by CPC Pain & Wellness SPV, LLC (“CPC”), which purported to provide notice of CPC's intent to nominate four candidates for election to the Company's five-member Board of Directors (the “Board”) at the 2024 Annual Meeting of Stockholders, is invalid. CPC, a special purpose vehicle that was recently forme.

XWELL Announces Director Candidate Nomination Notice Submitted by CPC is Invalid

XWELL Opens New XpresSpa Location at Philadelphia International Airport

New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings New location expands domestic footprint in busy Northeast corridor with labor lite tech forward service offerings

XWELL Opens New XpresSpa Location at Philadelphia International Airport

XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US

Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth Expanded service offering underscores XWELL's ongoing focus on delivering cost-effective wellness services that drive top-line growth

XWELL Continues to Innovate in Airport Wellness Space with New Massage Solutions: Introducing Ceragem V6 in select XpresSpa® Locations in US

XWELL, Inc. Reports First Quarter 2024 Results

NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the first quarter ended March 31, 2024.

XWELL, Inc. Reports First Quarter 2024 Results

XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport

Pilot program designed to expand service offerings and drive revenue growth Pilot program designed to expand service offerings and drive revenue growth

XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport

XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript

XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript

XWELL, Inc. (XWEL) Q4 2023 Earnings Call Transcript

XWELL, Inc. Reports Fiscal Year 2023 Results

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today reported results for the year ended December 31, 2023.

XWELL, Inc. Reports Fiscal Year 2023 Results

XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024

NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced that it will report results for the year ended December 31, 2023, on Tuesday, April 16, 2024, after the market close. The announcement will be followed by a webcast and conference call at 5:00 p.m.

XWELL, Inc. to Report Fiscal Year 2023 Financial Results on Tuesday, April 16, 2024

XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K

NEW YORK, April 01, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced plans to file a Form 12b-25 with the U.S. Securities and Exchange Commission regarding its Annual Report on Form 10-K for the year ended December 31, 2023. Additional time is needed for the Company to compile and analyze supporting documentation in order to finalize the Form 10-K and in order to permit the Company's independent registered public accounting firm to complete its audit of the consolidated financial statements included in the Form 10-K. The Company currently anticipates filing the Form 10-K as soon as practicable.

XWELL, Inc. Plans to File Form 12b-25 to Extend Filing Date of its Form 10-K

See News Rankings